Featured Research

from universities, journals, and other organizations

Improved effectiveness of chemotherapy for cancer

Date:
August 15, 2013
Source:
University of Bern
Summary:
Cancer cells often develop defence mechanisms which enable them to survive chemotherapy. A group of researchers have presented new solutions for preventing the development of such resistances.

Cancer cells often develop defense mechanisms which enable them to survive chemotherapy. A group of researchers from the Institutes of Pharmacology and Pathology in Bern present new solutions for preventing the development of such resistances.

Cells can break down damaged molecules as well as whole areas of the cells themselves by means of self-digestion and utilize the decomposition products resulting from this process for the production of energy and new molecules or cell parts. This process of self-digestion is called autophagy and can be considered a renovation of the cell. The generation of energy by means of autophagy plays a special role for the cells if they do not have enough nutrients, oxygen or growth factors.

However, autophagy can also be used by tumour cells in order to survive stress situations such as chemotherapy - they digest the destroyed cell parts and regenerate themselves. This makes them resistant to the therapy. Now, a group of scientists from the University of Bern under the direction of Hans-Uwe Simon from the Institute of Pharmacology has discovered that the autophagy of tumour cells can be influenced with pharmacological means. The findings reveal new therapy approaches for the treatment of cancer. The study is published today in Nature Communications

Preventing the reanimation of tumour cells

The researchers studied the importance of autophagy for tumour cells. Often, chemotherapy alone is not able to destroy all of the tumour cells. While some of the tumour cells survive the therapy by means of autophagy, others go through a so-called «mitotic catastrophe», a state in which they are no longer able to divide. If these damaged cells do not die, they can cause cancer again.

Now, however, the group of scientists gathered by Hans-Uwe Simon has found a way to prevent the survival of cancer cells after chemotherapy. They discovered a connection between autophagy and mitotic catastrophe: when the self-digestion of cancer cells was suppressed by means of pharmaceuticals, the mitotic catastrophe directly resulted in cell death. This way, the survival mechanisms of cancer cells were eliminated.

With this method, the effectiveness of the usual chemotherapy can be significantly improved: "We hope that, based on these findings, we will be able to develop new therapies which will prevent the chemoresistance of established tumours", said Hans-Uwe Simon, the head of the study.


Story Source:

The above story is based on materials provided by University of Bern. Note: Materials may be edited for content and length.


Journal Reference:

  1. Dipak Maskey, Shida Yousefi, Inès Schmid, Inti Zlobec, Aurel Perren, Robert Friis, Hans-Uwe Simon. ATG5 is induced by DNA-damaging agents and promotes mitotic catastrophe independent of autophagy. Nature Communications, 2013; 4 DOI: 10.1038/ncomms3130

Cite This Page:

University of Bern. "Improved effectiveness of chemotherapy for cancer." ScienceDaily. ScienceDaily, 15 August 2013. <www.sciencedaily.com/releases/2013/08/130815084753.htm>.
University of Bern. (2013, August 15). Improved effectiveness of chemotherapy for cancer. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/08/130815084753.htm
University of Bern. "Improved effectiveness of chemotherapy for cancer." ScienceDaily. www.sciencedaily.com/releases/2013/08/130815084753.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins